Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin
Abstract Background The CDSCO of India has authorized a combination of metformin hydrochloride, teneligliptin hydrochloride, and pioglitazone hydrochloride for the treatment of insulin-independent diabetes. For the purpose of estimating metformin, teneligliptin, and pioglitazone combinations as well...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SpringerOpen
2024-11-01
|
| Serier: | Future Journal of Pharmaceutical Sciences |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s43094-024-00746-7 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|